Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRSZacks Investment Research • 04/08/26
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026Business Wire • 04/06/26
Alcon Buy Rating Reaffirmed, Despite Failed STAAR Merger, As Eyecare Portfolio LeadsSeeking Alpha • 03/17/26
5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price UpsideZacks Investment Research • 03/10/26
Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma EducationGlobeNewsWire • 03/09/26
Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/YZacks Investment Research • 02/25/26
Alcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/25/26
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate SalesBusiness Wire • 02/24/26
Gear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 02/19/26
Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient TechnologyBusiness Wire • 02/17/26
Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week FreshBusiness Wire • 02/02/26
Alcon Inc. (ALC) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to AlconBusiness Wire • 01/06/26
Staar Surgical to reject Alcon takeover bid after failing to win shareholder backingReuters • 01/06/26